S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in
NASDAQ:GTHX

G1 Therapeutics SEC Filings & 10K Form

$20.43
+0.12 (+0.59 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$18.86
Now: $20.43
$21.40
50-Day Range
$20.31
MA: $24.91
$32.59
52-Week Range
$8.80
Now: $20.43
$37.07
Volume1.89 million shs
Average Volume1.78 million shs
Market Capitalization$857.22 million
P/E RatioN/A
Dividend YieldN/A
Beta2.44

SEC Filings

G1 Therapeutics (NASDAQ:GTHX) SEC Filings

DateFilerForm TypeView
03/04/2021
4:10 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
3:54 PM
G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
4:16 PM
G1 Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/18/2021
4:49 PM
G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
5:34 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2021
12:07 PM
G1 Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/08/2021
9:23 AM
FMR LLC (Filed by)
G1 Therapeutics (Subject)
Form SC 13G/A
02/03/2021
12:33 PM
G1 Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/29/2021
3:07 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
8:57 AM
BlackRock Inc. (Filed by)
G1 Therapeutics (Subject)
Form SC 13G/A
01/22/2021
5:47 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2021
4:31 PM
G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
5:02 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
5:25 PM
G1 Therapeutics (Issuer)
G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:22 PM
G1 Therapeutics (Issuer)
G1 Therapeutics (Issuer)
Gupta Soma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:18 PM
G1 Therapeutics (Issuer)
Hanson James S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:14 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:12 PM
G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:10 PM
Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
3:50 PM
G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
5:54 PM
G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
5:01 PM
G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:50 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
4:30 PM
G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
3:20 PM
G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
3:54 PM
G1 Therapeutics (Issuer)
MUIR GLENN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
3:33 PM
Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2020
9:27 AM
FMR LLC (Filed by)
G1 Therapeutics (Subject)
Form SC 13G/A
11/04/2020
4:15 PM
G1 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2020
3:05 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2020
3:08 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
8:10 AM
G1 Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
09/08/2020
7:38 PM
G1 Therapeutics (Issuer)
Hanson James S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
3:17 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2020
3:42 PM
G1 Therapeutics (Issuer)
Schwalm Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:40 PM
G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:39 PM
G1 Therapeutics (Issuer)
MUIR GLENN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:38 PM
G1 Therapeutics (Issuer)
Nicholson Garry A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:37 PM
Deese Willie A (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:34 PM
Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:32 PM
ESHELMAN FREDRIC N (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
5:08 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
4:16 PM
G1 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2020
3:05 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2020
3:53 PM
G1 Therapeutics (Issuer)
Gupta Soma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
3:52 PM
G1 Therapeutics (Issuer)
Gupta Soma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/16/2020
6:00 AM
G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
6:00 AM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
6:00 AM
G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
3:44 PM
G1 Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/11/2020
3:20 PM
G1 Therapeutics (Subject)
Hatteras Venture Partners IV SBIC, LP (Filed by)
Form SC 13G/A
02/03/2020
4:21 PM
G1 Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/28/2020
10:49 AM
G1 Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/24/2020
3:59 PM
G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:58 PM
G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:58 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
5:12 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
3:31 PM
G1 Therapeutics (Filer)
Form 8-K/A
11/05/2019
4:16 PM
G1 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
3:07 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
4:29 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
8:56 PM
G1 Therapeutics (Subject)
Lumira Capital Investment Management Inc. (Filed by)
Form SC 13G/A
08/07/2019
4:16 PM
G1 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2019
3:29 PM
Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
3:28 PM
Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/19/2019
8:58 PM
G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
5:05 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:38 PM
ESHELMAN FREDRIC N (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:36 PM
G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:35 PM
Deese Willie A (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:33 PM
G1 Therapeutics (Issuer)
Nicholson Garry A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:32 PM
G1 Therapeutics (Issuer)
MUIR GLENN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:31 PM
G1 Therapeutics (Issuer)
Schwalm Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:30 PM
G1 Therapeutics (Issuer)
WITTY ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:26 PM
G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
4:16 PM
G1 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:26 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:10 PM
G1 Therapeutics (Filer)
Form DEFA14A
04/30/2019
3:05 PM
G1 Therapeutics (Filer)
Form DEF 14A
04/29/2019
3:07 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:34 PM
G1 Therapeutics (Filer)
Form 10-K/A
02/28/2019
3:08 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
3:51 PM
G1 Therapeutics (Subject)
Hatteras Venture Partners IV SBIC, LP (Filed by)
Form SC 13G/A
01/28/2019
8:10 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
11:13 AM
FRANKLIN RESOURCES INC (Filed by)
G1 Therapeutics (Subject)
Form SC 13G/A
01/17/2019
4:52 PM
G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
4:52 PM
G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2019
8:37 AM
G1 Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
01/02/2019
4:46 PM
G1 Therapeutics (Issuer)
Strum Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:32 PM
G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:29 PM
G1 Therapeutics (Issuer)
Hanson James S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:29 PM
G1 Therapeutics (Issuer)
PHILLIPS BARCLAY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:29 PM
G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:29 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:28 PM
DEMAREE JOHN (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:28 PM
G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
3:59 PM
G1 Therapeutics (Issuer)
Hanson James S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
3:59 PM
G1 Therapeutics (Issuer)
Schwalm Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2018
4:24 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
3:27 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.